tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
Advertisement

Takeda Pharmaceutical Company (TAK) Revenue

Compare
1,300 Followers

Takeda Pharmaceutical Company Revenue

Takeda Pharmaceutical Company had a revenue of 1.05T in the quarter ending Dec 31, 2024, with -7.93%. This bring the company's revenue in the last twelve months to 4.58T, Decreased 0.06%. In the fiscal year ending Dec 31, 2024, Takeda Pharmaceutical Company had annual revenue of 4.58T with 7.45% growth.
Revenue (ttm)
4.58T
Revenue Growth
1.36%
P/S Ratio
0.01
Revenue/Employee
$92,967,898
Employees
49,281
Market Cap
$46.99B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
4.58T317.79B+7.45%
Dec 31, 2023
4.26T236.28B+5.87%
Dec 31, 2022
4.03T458.47B+12.85%
Dec 31, 2021
3.57T371.19B+11.61%
Dec 31, 2020
3.20T-93.38B-2.84%
Dec 31, 2019
3.29T1.19T+56.93%
Dec 31, 2018
2.10T326.69B+18.45%
Dec 31, 2017
1.77T38.48B+2.22%
Dec 31, 2016
1.73T
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis